Enlivex director Havron Avraham reports holdings

Enlivex Ltd. director Havron Avraham filed an initial ownership report showing a direct stake in ordinary shares and stock options.

Rhea-AI Filing Summary

Enlivex Ltd. director Havron Avraham filed an initial ownership report showing a direct stake in ordinary shares and stock options. He holds 183,836 ordinary shares and options over 53,192 shares at an exercise price of $2.69 expiring on December 31, 2033, plus options over 3,382 shares at $5.34 expiring on November 17, 2032. The latter option grant vests in equal annual installments over four years beginning November 17, 2023.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider Havron Avraham

Role Director

Type	Security	Shares	Price	Value
holding	Option (right to buy)	--	--	--
holding	Option (right to buy)	--	--	--
holding	Ordinary Shares, par value NIS 0.40 per share	--	--	--

Holdings After Transaction: Option (right to buy) — 56,574 contracts (Direct); Ordinary Shares, par value NIS 0.40 per share — 183,836 shares (Direct)

Footnotes (1)

1. F1. The option vests ratably on an annual basis for 4 consecutive years beginning on November 17, 2023.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Enlivex (ENLV) director Havron Avraham report in this Form 3?

Havron Avraham reports his initial ownership in Enlivex. He directly holds 183,836 ordinary shares and stock options over additional shares, establishing his equity stake as a company director at the time of this filing.

How many Enlivex (ENLV) ordinary shares does Havron Avraham own directly?

He directly owns 183,836 Enlivex ordinary shares. This position reflects his existing equity stake, separate from any stock options that could expand his ownership if exercised in the future.

What stock options does Havron Avraham hold in Enlivex (ENLV)?

He holds options to acquire 53,192 ordinary shares at $2.69 per share, expiring December 31, 2033, and options over 3,382 shares at $5.34 per share, expiring November 17, 2032.

How do Havron Avraham’s Enlivex (ENLV) options vest over time?

One option grant vests ratably on an annual basis for four consecutive years beginning on November 17, 2023. This means a portion becomes exercisable each year across that four-year period.

Does this Enlivex (ENLV) Form 3 show any recent insider buying or selling?

No recent insider buying or selling is shown. The Form 3 is an initial ownership statement listing Havron Avraham’s existing ordinary shares and option awards, without reporting new purchase or sale transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 07:03 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Havron Avraham

(Last) (First) (Middle)

14 EINSTEIN STREET

(Street)

NESS ZIONA 7403618

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Enlivex Ltd. [ ENLV ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares, par value NIS 0.40 per share	183,836	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (right to buy)	06/01/2019	12/31/2033	Ordinary Shares, par value NIS 0.40 per share	53,192	$2.69	D
Option (right to buy)	(1)	11/17/2032	Ordinary Shares, par value NIS 0.40 per share	3,382	$5.34	D

Explanation of Responses:

1. The option vests ratably on an annual basis for 4 consecutive years beginning on November 17, 2023.

Remarks:

See Exhibit 24.1 - Power of Attorney

	/s/ Shachar Shlosberger, Attorney-in-Fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)